Trump's NIH cuts are gutting university labs that fuel Big Pharma's drug pipeline and pushing U.S. biotech jobs, research, ...

That challenge, of finding or building good, useable data sets, is also one of the biggest differentiators in an increasingly ...

The US Supreme Court on Monday declined to review a federal appeals court decision that Merck Sharpe & Dohme Corp. couldn’t ...

A Roots Analysis study showed the market for ADC manufacturing is $1.79 billion today, but is expected to grow to $7 billion ...

Merck ( MRK) is a global biopharmaceutical giant with a diversified portfolio that spans across oncology, vaccines, ...

Biogen has emerged as a potential front-runner at the Cannes Lions International Festival of Creativity, snagging four spots ...

During a live event, Hari Deshpande, MD, and participants discussed the DeFi trial and the management of nirogacestat in ...

Amid a spate of high-profile investments in U.S. pharmaceutical production, two contract manufacturers are getting in on the ...

The recent experience of Chinese biotech companies in developing their own drug candidates and inking deals with larger ...

Navigating a complex drug development landscape, sponsors must rethink their approach to risk in study design and execution.